A webcast of the presentation will be available by selecting Events and Presentations under the News & Events tab in the Investors section on candeltx.com. A replay of the webcast will be archived for ...

Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its ...

BURLINGTON - Azenta, Inc., a life science company at 200 Summit Dr. in Burlington, recently announced the launch of a long-read Whole Genome Sequencing (WGS) test for clinical applications. Azenta ...

OR502 was well tolerated up to the highest dose level with no DLTs, SAEs or Grade ≥ 3 treatment-related AEs. The study showed promising early efficacy signals in monotherapy, including 2 PR and 9 SD ...

South freshman Hope Julian. By Mike London [email protected] LANDIS — South Rowan’s Hope Julian is wired different. Different in a good way, but definitely different. She is a freshman ...

IGI to present first-data from phase I study of cancer drug in ASH annual meeting: Our Bureau, New Delhi Thursday, November 7, 2024, 11:30 Hrs [IST] Ichnos Glenmark Innovation (IG ...

In this special edition of Her Campus’s Dorm Diaries series, Gen Zers from across the country share their experiences on ...

Research and development expense was $15.5 million for the third quarter of 2024, as compared to $7.6 million for the prior ...

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious ...